Pavan Cheruvu is CEO at Axovant Gene Therapies Ltd. (AXGT). They have made 3 open-market trades across 2 companies since 2019, most recently 2021-12-08.
CIK 0001731741
3 open-market purchases totalling $493K since 2019, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.